HTA268 Impact of Independence and Transparency on Drug Availability and Time to Market: EU4 Qualitative and Quantitative Analysis of Pricing, Reimbursement, and Access Processes
Abstract
Authors
C Castillo M Vázquez Roso T Vico E Vidal-Barraquer